NCT01916330

Completed

Development of Pharmacokinetics Model in Pregnancy Women and...

Seoul National University Hospital Source

Compare

Other study identifiers

Sponsor study identifier

SNUHOB-PK1

Study Type

observational

Actual enrollment (reported)

96

Locations

1 country

Sites

1

Timeline

Study Start

January 14, 2013

Actual (reported)

Primary Completion

February 24, 2014

Actual (reported)

Study Completion

Not reported

Date not reported

Brief Summary

Pharmacokinetics analysis and development of pharmacokinetics model in pregnancy women and fetus

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 96 participants
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 14, 2013
Actual (reported)
First Submitted
July 29, 2013
Actual (reported)
First Posted
August 5, 2013
Actual (reported)
Primary Completion
February 24, 2014
Actual (reported)

Last Updated: April 25, 2019
Status Verified: April 2019
Last Update Submitted: April 23, 2019

Conditions

Preterm Labor Preterm Premature Rupture of Membrane (PPROM)

Outcome Measures

Primary Outcomes (1)

Analysis of drug concentration
drug (dexamethasone, clarithromycin)
Day 1 after delivery

Eligibility Criteria

Age20 Years - 50 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodNon-Probability Sample

Study Population

preterm labor, PPROM in pregnant women from tertiary university hospital

You may qualify if:

\<= age \< 50

Sponsors & Collaborators

Seoul National University Hospital
Otherlead

Study Sites (1)

Seoul National University Hospital

Seoul, 110744, South Korea

MeSH Terms

Conditions

Obstetric Labor, PrematurePreterm Premature Rupture of the Membranes

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

Joong Shin Park, MD PhD
Seoul National University Hospital
PRINCIPAL INVESTIGATOR

Enrollment

96 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 29, 2013

First Posted

August 5, 2013

Study Start

January 14, 2013

Actual (reported)

NCT01985594

Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial

Phase 2Unknown

NCT02262481

Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

Not ApplicableCompleted

NCT02132533

Nifedipine for Acute Tocolysis of Preterm Labor

Phase 3Completed

NCT02108886

Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth

Phase 2Unknown

NCT01518816

Role of Serum Total Antioxidant Level in Preterm Labor

Unknown

NCT02090920

Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor

Completed

pregnant women who were administered intramuscular dexamethasone (ex) preterm labor)

pregnant women who were administered PO clarithromycin (ex) PPROM/intrauterine infection or inflammation)

You may not qualify if:

who deny the study entrance
who administered study drug before transfer to tertiary hospital

Contact the study team to confirm eligibility.

Primary Completion

February 24, 2014

Actual (reported)

Last Updated

April 25, 2019

Record last verified: 2019-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01916330
Data provider: ClinicalTrials.gov
Source updated: 2019-04-25
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:26 UTC

Locations

KR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations